drugset / Trial / NCT00052117

Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens

NCT00052117

Phase 2 Completed 300 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a 48 week study for HIV-infected patients who have failed several regimens including PI's, NNRTs and NRTIs. Patients will be randomly selected to be in 1 of 4 groups. Three of the 4 groups will contain capravirine in different doses combined with Kaletra and nucleosides and one of the groups will be a combination of Kaletra and nucleosides without the capravirine.

Timeline

Start
2003-01
Primary completion
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Capravirine Small molecule
Background Ritonavir Other / unclassified